Marker Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline ERIC Q1 2026 Earnings EPS Beats Estimates by Over 20 Shares Rise WMS Q1 2026 Earnings EPS Surges Past Estimates Despite Negative Market Reaction SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline LGL Q1 2026 Earnings Net Loss Misses Estimates Stock Edges Higher YELP Q1 2026 Earnings EPS Beats Estimates by 117 Stock Gains 23